Copyright
©2013 Baishideng Publishing Group Co.
World J Gastroenterol. Oct 28, 2013; 19(40): 6774-6783
Published online Oct 28, 2013. doi: 10.3748/wjg.v19.i40.6774
Published online Oct 28, 2013. doi: 10.3748/wjg.v19.i40.6774
Ref. | Study | Year | Operation | n | Type of pouch | Findings | % of adenoma | Time to neoplasia |
Beart et al[17] | Case | 1982 | Kock | 1 | Kock pouch | Tubulovillous Adenomas | 6 yr | |
Wolfstein et al[18] | Case | 1982 | IAA | 2 | Soave | Adenomas in 2 pts | 3 and 7 yr | |
Shepherd et al[19] | Retro | 1987 | IPAA | 12 | N | Tubular Adenoma in 2 pts | 16.7 | |
Stryker et al[20] | Case | 1987 | Brooke ileostomy | 1 | Kock pouch | Tubular Adenomas | 12 yr | |
Nugent et al[16] | Retro | 1993 | IPAA | 38 | N | Tubular Adenoma in 5 pts | 13.2 | 4 yr (1-7) |
Bertoni[21] | Pros | 1995 | IAA | 3 | N | Tubular Adenoma in 2 pts | 66.7 | 53.7-75.4 mo |
Wu et al[22] | Pros | 1998 | IPAA | 26 | S/J-pouch 9/16, 1 N | Tubular Adenoma in 11 pts | 42.3 | 1-14 yr |
Valle et al[23] | Case | 2001 | IPAA | 5 | N | Adenomas | 20 | 5 yr |
Thompson-Fawcett et al[24] | Pros | 2001 | Kock 5, IPAA 28 | 33 | N | Adenoma in 14 pts (with microadenoma 20 pts) | 42.4 (60.6) | 7 yr (1-19) |
Parc et al[4] | Pros | 2001 | IPAA | 85 | J-pouch | 30 pts (28 grossly visible, 2 microadenoma) | 35.3 | Cumulative risk of 7%, 35%, and 75% at 5, 10, and 15 yr |
Polese et al[25] | Retro | 2002 | IPAA | 46 | S/W/J-pouch 2/1/43, Kock 4 | Adenoma in 2 of 30 pts | 6.7 | risk of Adenoma after 8 yr; 20%, (9-11 yr) |
Beveridge et al[26] | Case | 2004 | IPAA | 2 | J-pouch 1, Kock 1 | 2 large VA, VA | 4-10 yr | |
Vrouenraets et al[27] | Case | 2004 | IPAA | 1 | J-pouch | Adenomas with focal severe dysplastic change | 6 yr | |
Groves et al[28] | Pros | 2005 | Kock 4, IPAA 56 | 60 | W/J-pouch 13/43, Kock 4 | Mild dysplasia 23, more advanced 11 | 56.7 | 6 yr (1-17) |
Nilubol et al[29] | Pros | 2007 | IPAA | 10 | N | Tubular Adenoma in 1of 9 pts | 11.1 | 11.3 yr |
Moussata et al[30] | Retro | 2008 | IPAA | 23 | N | Low-grade 16, high-grade 1 | 73.9 | 4.76 yr (1-14) |
Friederich et al[31] | Pros | 2008 | IPAA | 212 | N | Adenoma 74 pts, AAP 25 pts | 46.7 | Cumulative risk of 16% and 42.2% at 5 and 10 yr |
Schulz et al[32] | Pros | 2008 | IPAA | 35 | N | Low-grade 8 | 22.8 | mean of 5 yr |
Tajika et al[33] | Retro | 2009 | Kock 8, IPAA 16 | 24 | J-pouch | 16 pts, (advanced 1, carcinoma 2) | 66.7 | Cumulative risk of 13%, 43%, and 72% at 5, 10, and 20 yr |
Kang et al[34] | Case | 2010 | Kock | 2 | Kock pouch | 2 (the largest one is 15mm in size) | ||
Banasiewicz et al[35] | Pros | 2011 | IPAA | 165 | J-pouch | Low-grade 13, high-grade 8, neoplasia 5 | 15.8 | Cumulative risk of 50%, Low-grade at 15 yr, high-grade at 17.5 yr, neoplasia 18.5 yr |
Tonelli et al[36] | Pros | 2012 | IPAA | 69 | S/J-pouch 25/29, SIMM 15 | Adenoma 25 pts, carcinoma 2 pts | 39.1 | Cumulative risk of 28.5% at 5 yr |
Makni et al[37] | Case | 2012 | IPAA | 1 | J-pouch | Adenoma and carcinoma | 10 yr | |
Wasmuth et al[38] | Retro | 2013 | IPAA | 61 | N | 14 pts | 23 | Estimated cumulative rate of first Adenoma diagnosed was 38% |
Pommaret[39] | Retro | 2013 | IPAA | 118 | J-pouch | 57 pts (12 advanced Adenomas) | 48.3 | 15 yr |
Ref. | Year | Sex | Operation | Type of pouch | Staging of initial surgery | Age of pouch (yr) | Shape | Size (mm) | Staging of pouch cancer | No. of pouch polyps | Time to cancer (yr) | Outcome | Interval since last endoscopy (yr) |
Bassuini et al[40] | 1996 | M | IPAA | /handsewn | No cancer | 28 | Large polypoid | N | T3,N+ | N | 3 | N | No follow-up |
Palkar et al[41] | 1997 | F | IPAA | J-pouch handsewn | No cancer | 39 | Large polypoid | 40 × 35 | T4N0 | Exist | 4.7 | Alive | 0.3 |
Kim et al[42] | 1997 | N | N | N | N | N | N | N | N | N | N | N | N |
Cherki et al[43] | 2003 | F | IPAA | J-pouch handsewn | TisN0M0 | 35 | N | N | T3N1M1 | N | 3.5 | Died | 0.5 |
Linehan et al[44] | 2007 | M | IPAA | /double stapled | Dukes A | 30 | N | N | T3N0 | N | 9 | Alive | No follow-up |
Friederich et al[31] | 2008 | M | IPAA | /handsewn | No cancer | 21.3 | N | N | Dukes C | 0 | 14 | N | 4.4 |
M | IPAA | /stapled | No cancer | 26.7 | N | N | Dukes B | 0 | 10 | N | 2.1 | ||
M | IPAA | /handsewn | No cancer | 16 | N | N | Dukes B | N | 16 | N | No follow-up | ||
F | IPAA | /stapled | No cancer | 29.6 | N | N | Dukes B | exist | 6 | N | 0.6 | ||
Tajika et al[45] | 2009 | F | IPAA | J-pouch/handsewn | TisN0M0 | 46 | Type 2 | 30 × 25 | T4N2M0 | 0 | 8.6 | Died 3Y | 0.75 |
M | Kock | Kock/handsewn | No cancer | 48 | Type 1 | 40 × 35 | T3N0M0 | 10 < | 20 | Died by U | No follow-up | ||
Ault et al[46] | 2009 | M | IPAA | S-pouch/handsewn | Four cancer | 61 | ND | 20-30 | T2N1 | N | 11 | Died by U | 6 |
F | IPAA | ND | No cancer | 40 | Type 1 | N | N | N | 13 | meta | No follow-up | ||
Lee et al[47] | 2009 | F | IPAA | J-pouch/ | T2N0 | 56 | Type 2 | 30 × 25 | T3N2 | 0 | 7 | meta 2Y | 4 |
Banasiewicz et al[35] | 2011 | N | IPAA | J-pouch/ | N | N | N | N | N | N | N | N | N |
N | IPAA | J-pouch/ | N | N | N | N | N | N | N | N | N | ||
N | IPAA | J-pouch/ | N | N | N | N | N | N | N | N | N | ||
N | IPAA | J-pouch/ | N | N | N | N | N | N | N | N | N | ||
Tonelli et al[36] | 2012 | M | IPAA | S-pouch/handsewn | No cancer | 26 | Type 2 | 20 < | T3N0M0 | ND | 3 | Died 6 mo | 1 |
F | IPAA | S-pouch/handsewn | TisN0M0 | 47 | IIa + IIc | N | T2N0M0 | 0 | 11 | Alive at 56 mo | 0.5 | ||
Makni et al[37] | 2012 | F | IPAA | J-pouch/ | No cancer | 26 | N | 20 | N | Many | 10 | Died 1Y+ | 0.66 |
- Citation: Tajika M, Niwa Y, Bhatia V, Tanaka T, Ishihara M, Yamao K. Risk of ileal pouch neoplasms in patients with familial adenomatous polyposis. World J Gastroenterol 2013; 19(40): 6774-6783
- URL: https://www.wjgnet.com/1007-9327/full/v19/i40/6774.htm
- DOI: https://dx.doi.org/10.3748/wjg.v19.i40.6774